Annual Retained Earnings
-$169.60 M
-$64.47 M-61.32%
December 31, 2023
Summary
- As of March 4, 2025, JSPR annual retained earnings is -$169.60 million, with the most recent change of -$64.47 million (-61.32%) on December 31, 2023.
- During the last 3 years, JSPR annual retained earnings has fallen by -$132.79 million (-360.71%).
- JSPR annual retained earnings is now -360.71% below its all-time high of -$36.81 million, reached on December 31, 2020.
Performance
JSPR Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$216.55 M
-$18.64 M-9.42%
September 30, 2024
Summary
- As of March 4, 2025, JSPR quarterly retained earnings is -$216.55 million, with the most recent change of -$18.64 million (-9.42%) on September 30, 2024.
- Over the past year, JSPR quarterly retained earnings has dropped by -$63.53 million (-41.52%).
- JSPR quarterly retained earnings is now -488.24% below its all-time high of -$36.81 million, reached on December 31, 2020.
Performance
JSPR Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
JSPR Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -61.3% | -41.5% |
| 3 y3 years | -360.7% | -41.5% |
| 5 y5 years | -360.7% | -41.5% |
JSPR Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -151.4% | at low | -221.1% | at low |
| 5 y | 5-year | -360.7% | at low | -488.2% | at low |
| alltime | all time | -360.7% | at low | -488.2% | at low |
Jasper Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$216.55 M(+9.4%) |
| Jun 2024 | - | -$197.91 M(+8.0%) |
| Mar 2024 | - | -$183.33 M(+8.1%) |
| Dec 2023 | -$169.60 M(+61.3%) | -$169.60 M(+10.8%) |
| Sep 2023 | - | -$153.02 M(+12.9%) |
| Jun 2023 | - | -$135.47 M(+13.5%) |
| Mar 2023 | - | -$119.39 M(+13.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -$105.14 M(+55.9%) | -$105.14 M(+14.4%) |
| Sep 2022 | - | -$91.92 M(+14.8%) |
| Jun 2022 | - | -$80.06 M(+14.9%) |
| Mar 2022 | - | -$69.66 M(+3.3%) |
| Dec 2021 | -$67.45 M(+83.2%) | -$67.45 M(+15.5%) |
| Sep 2021 | - | -$58.39 M(+58.6%) |
| Dec 2020 | -$36.81 M | -$36.81 M |
FAQ
- What is Jasper Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Jasper Therapeutics?
- What is Jasper Therapeutics annual retained earnings year-on-year change?
- What is Jasper Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Jasper Therapeutics?
- What is Jasper Therapeutics quarterly retained earnings year-on-year change?
What is Jasper Therapeutics annual retained earnings?
The current annual retained earnings of JSPR is -$169.60 M
What is the all time high annual retained earnings for Jasper Therapeutics?
Jasper Therapeutics all-time high annual retained earnings is -$36.81 M
What is Jasper Therapeutics annual retained earnings year-on-year change?
Over the past year, JSPR annual retained earnings has changed by -$64.47 M (-61.32%)
What is Jasper Therapeutics quarterly retained earnings?
The current quarterly retained earnings of JSPR is -$216.55 M
What is the all time high quarterly retained earnings for Jasper Therapeutics?
Jasper Therapeutics all-time high quarterly retained earnings is -$36.81 M
What is Jasper Therapeutics quarterly retained earnings year-on-year change?
Over the past year, JSPR quarterly retained earnings has changed by -$63.53 M (-41.52%)